Oct 28 (Reuters) - Life sciences group Thermo Fisher
is nearing an all-cash takeover of drug trial software
maker Clario in a deal that could value the healthcare
technology group at approximately $10 billion, the Financial
Times reported on Tuesday.
Reuters could not immediately verify the report.